RA

Rijwan Ahamad

Director Director DIN 09454540
DIN 09454540 First appointment Jul 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2021
Shareholding value Locked Premium profile

About Rijwan Ahamad

Data last updated:

Rijwan Ahamad has 5 years in corporate governance. Formerly with 1 company, such as Almomed Diagnostics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09454540
Primary Designation Director
First Appointment 11 Jul 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Almomed Diagnostics Private Limited U85100PN2012PTC145234
Director11 Jul 20212012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Almomed Diagnostics Private Limited
Premium access

Shareholding and investment profile for Rijwan Ahamad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rijwan Ahamad

Rijwan Ahamad has 5 years in corporate governance. Formerly with 1 company, such as Almomed Diagnostics Private Limited. Engaged in General Business. Contributes to corporate operations.

Rijwan Ahamad is associated with 0 companies as a director.

Rijwan Ahamad has expertise in General Business.

Rijwan Ahamad has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available